Texas Neurology

Dallas, Texas 75214

5 studies enrolling now · 31 studies all time

What they study most

ALS, Alzheimer Disease, Alzheimer's Disease, Amyotrophic Lateral Sclerosis, Asymptomatic ALS Gene Carriers, Chronic Migraine, Cryptogenic Sensory Polyneuropathy, Episodic Migraine, Extra-axial Tumors, Flail Arm ALS, Headache Migraine Chronic, Healthy Controls

Studies at this site

• Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS — Recruiting now
• Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis — Recruiting now
• PREVENT ALL ALS Study — Recruiting now
• ASSESS ALL ALS Study — Recruiting now
• HEALEY ALS Platform Trial - Master Protocol — Running, not enrolling
• A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults — Running, not enrolling
• Evaluation of Gadolinium Based Contrast Agents for Portable MR Imaging Systems — Enrolling by invitation
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM — Running, not enrolling
• Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and CNMAu8.EAP02 for ALS — NO_LONGER_AVAILABLE
• Intermediate Expanded Access Protocol CNMAu8.EAP04 — TEMPORARILY_NOT_AVAILABLE
• A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis — Completed
• A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling
• Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis — Running, not enrolling
• A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2) — NO_LONGER_AVAILABLE
• Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment — Running, not enrolling
• CogMS - A Real-world Study Into Cognitive Impairment in People With Multiple Sclerosis — Completed
• Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients — Completed
• Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS — Completed
• Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS — Completed
• Phase 3 Extension Study of Dexpramipexole in ALS — Stopped early
• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext — Completed
• Phase 3 Study of Dexpramipexole in ALS — Completed
• A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) — Completed
• Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year — Completed
• Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS) — Completed
• Answer ALS: Individualized Initiative for ALS Discovery — Completed
• Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations — Completed
• Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults — Completed
• Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis — Completed
• Clinical Trial Ceftriaxone in Subjects With ALS — Completed